Broadwood Partners, L.P., 10% Owner at Oncocyte Corp (OCX), bought 10,331,390 shares at $2.05 ($21.2M) on 2025-02-06, disclosed to the SEC on 2025-02-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.05 | 660,207 | $1.4M | 6.4% |
| 2 | $2.05 | 660,207 | $1.4M | 6.4% |
| 3 | $2.05 | 4,505,488 | $9.2M | 43.6% |
| 4 | $2.05 | 4,505,488 | $9.2M | 43.6% |
| Total | $2.05 avg | 10,331,390 | $21.2M | 100% |
| Filing → |
| STAA | BUY | 2026-03-13 | $12.3M | — | Filing → |
| STAA | BUY | 2026-01-08 | $8.8M | — | Filing → |
| STAA | BUY | 2025-04-07 | $27.2M | — | Filing → |